Related references
Note: Only part of the references are listed.The Metabolic Role and Therapeutic Potential of the Microbiome
Louise E. Olofsson et al.
ENDOCRINE REVIEWS (2022)
Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism
Arash Haghikia et al.
EUROPEAN HEART JOURNAL (2022)
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Ramy Younes et al.
GUT (2022)
Relationship Between Hepatic Gene Expression, Intestinal Microbiota, and Inferred Functional Metagenomic Analysis in NAFLD
Paulina Pettinelli et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2022)
Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives
Natalia Vallianou et al.
BIOMOLECULES (2022)
Nonalcoholic Fatty Liver Disease and the Gut-Liver Axis: Exploring an Undernutrition Perspective
Kylynda C. Bauer et al.
GASTROENTEROLOGY (2022)
A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease
Runtan Cheng et al.
NATURE COMMUNICATIONS (2022)
The immune response as a therapeutic target in non-alcoholic fatty liver disease
Nicolas Ortiz-Lopez et al.
FRONTIERS IN IMMUNOLOGY (2022)
Microbiota in health and diseases
Kaijian Hou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Gut microbiota in human metabolic health and disease
Yong Fan et al.
NATURE REVIEWS MICROBIOLOGY (2021)
Intestinal hypoxia-inducible factor 2α regulates lactate levels to shape the gut microbiome and alter thermogenesis
Qing Wu et al.
CELL METABOLISM (2021)
Obesity and cardiovascular health: the size of the problem
Annika Rosengren
EUROPEAN HEART JOURNAL (2021)
Effect of Microbiome on Non-Alcoholic Fatty Liver Disease and the Role of Probiotics, Prebiotics, and Biogenics
Mayumi Nagashimada et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)
Adaptive immunity: an emerging player in the progression of NAFLD
Salvatore Sutti et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Nonalcoholic fatty liver disease: modulating gut microbiota to improve severity?
Judith Aron-Wisnewsky et al.
GASTROENTEROLOGY (2020)
Role of gut microbiota in type 2 diabetes pathophysiology
Manoj Gurung et al.
EBIOMEDICINE (2020)
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Sara Vieira-Silva et al.
NATURE (2020)
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron-Wisnewsky et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Creatine metabolism: energy homeostasis, immunity and cancer biology
Lawrence Kazak et al.
NATURE REVIEWS ENDOCRINOLOGY (2020)
The role of the microbiota in human genetic adaptation
Taichi A. Suzuki et al.
SCIENCE (2020)
Gut Microbiota and IL-17A: Physiological and Pathological Responses
Banafsheh Douzandeh-Mobarrez et al.
PROBIOTICS AND ANTIMICROBIAL PROTEINS (2019)
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver disease
Huikuan Chu et al.
GUT (2019)
Nonalcoholic fatty liver disease and the gut microbiome: Are bacteria responsible for fatty liver?
Tien S. Dong et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2019)
Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study
Clara Depommier et al.
NATURE MEDICINE (2019)
Probiotics and prebiotics in intestinal health and disease: from biology to the clinic
Mary Ellen Sanders et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Immune control of the microbiota prevents obesity
Yuhao Wang et al.
SCIENCE (2019)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease (vol 25, pg 1054, 2017)
Rohit Loomba et al.
CELL METABOLISM (2019)
Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Chencheng Xie et al.
NUTRIENTS (2019)
Manipulating the Microbiome With Fecal Transplantation to Treat Ulcerative Colitis
Colleen R. Kelly et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans
Abraham S. Meijnikman et al.
ENDOCRINE REVIEWS (2018)
Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in NAFLD
Na Jiao et al.
GUT (2018)
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD)
Stefania Bruzzi et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles et al.
NATURE MEDICINE (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Current understanding of the human microbiome
Jack A. Gilbert et al.
NATURE MEDICINE (2018)
The Inhibitory Innate Immune Sensor NLRP12 Maintains a Threshold against Obesity by Regulating Gut Microbiota Homeostasis
Agnieszka D. Truax et al.
CELL HOST & MICROBE (2018)
Environment dominates over host genetics in shaping human gut microbiota
Daphna Rothschild et al.
NATURE (2018)
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Lulu Sun et al.
NATURE MEDICINE (2018)
Gut Microbiota Profiling of Pediatric Nonalcoholic Fatty Liver Disease and Obese Patients Unveiled by an Integrated Meta-omics-Based Approach
Federica Del Chierico et al.
HEPATOLOGY (2017)
GUT MICROBIOTA Mucin-munching bacteria modulate glucose metabolism
Tim Geach
NATURE REVIEWS ENDOCRINOLOGY (2017)
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches
R. Balfour Sartor et al.
GASTROENTEROLOGY (2017)
Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics
Mireia Lopez-Siles et al.
ISME JOURNAL (2017)
Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice
Eveliina Munukka et al.
ISME JOURNAL (2017)
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Louis J. Cohen et al.
NATURE (2017)
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Ruixin Liu et al.
NATURE MEDICINE (2017)
Microbiome and colorectal cancer: Unraveling host-microbiota interactions in colitis-associated colorectal cancer development
Mingsong Kang et al.
SEMINARS IN IMMUNOLOGY (2017)
Nonalcoholic Fatty Liver Disease Is Exacerbated in High-Fat Diet-Fed Gnotobiotic Mice by Colonization with the Gut Microbiota from Patients with Nonalcoholic Steatohepatitis
Chien-Chao Chiu et al.
NUTRIENTS (2017)
Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular Carcinoma
Ana L. Gomes et al.
CANCER CELL (2016)
IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
Isaac T. W. Harley et al.
HEPATOLOGY (2014)
Microbial fingerprinting detects intestinal microbiota dysbiosis in Zebrafish models with chemically-induced enterocolitis
Qi He et al.
BMC MICROBIOLOGY (2013)
Molecular Characterization of Fecal Microbiota in Patients with Viral Diarrhea
Chaofeng Ma et al.
CURRENT MICROBIOLOGY (2011)
Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR
T Rinttila et al.
JOURNAL OF APPLIED MICROBIOLOGY (2004)
Share Paper
